PACS Group, Inc. (PACS)
PACS Group, Inc. (PACS)
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income | 80,668 | 59,785 | 52,330 | 50,966 |
| Depreciation and amortization | 18,077 | 15,379 | 14,401 | 13,178 |
| Amortization of deferred financing fees | 787 | 787 | 787 | 787 |
| Stock-based compensation | 20,348 | 15,747 | 12,516 | 13,604 |
| (gain) loss on investment in partnership | 455 | 27 | -488 | -312 |
| Gain on insurance subsidiary deposits and investments | 131 | 892 | 1,140 | 1,212 |
| Deferred taxes | -12,461 | 13,804 | -14,508 | 2,551 |
| Noncash lease expense | 11,000 | 11,383 | 11,931 | 12,437 |
| Other noncash operating activities, net | 364 | 463 | 81 | -269 |
| Accounts receivable, net | 19,909 | -152 | -9,847 | -42,549 |
| Other receivables | 11,218 | 7,537 | 14,783 | -9,380 |
| Prepaid expenses and other current assets | -77,201 | 62,560 | -16,873 | 35,636 |
| Other assets | 3,608 | -5,024 | -6,842 | 10,693 |
| Escrow funds | -144 | -6,014 | 1,012 | 1,596 |
| Operating lease liabilities | -1,062 | 137 | -328 | -1,069 |
| Accounts payable | -13,932 | -12,211 | 31,807 | -25,346 |
| Accrued payroll and benefits | 55,045 | -65,369 | 62,402 | -17,487 |
| Accrued self-insurance liabilities | 25,327 | 23,161 | 7,306 | 28,919 |
| Refund liability | 0 | -4 | 7,538 | 11,441 |
| Other accrued expenses | 14,723 | -24,073 | -68,575 | 83,595 |
| Other liabilities | -4,573 | 17,447 | 69,993 | -123,837 |
| Net cash provided by operating activities | 236,335 | -3,390 | 204,796 | 52,574 |
| Investment in partnerships | NaN | 0 | 0 | 0 |
| Non-operating distributions from investment in partnership | 1,437 | 1,417 | 1,354 | 1,521 |
| Purchase of available-for-sale securities | NaN | 6,050 | 51 | 15,111 |
| Sale of available-for-sale securities | NaN | 0 | NaN | NaN |
| Purchase of equity securities | 20,050 | NaN | NaN | NaN |
| Acquisition of facilities | 86,519 | 63,157 | 80,351 | 243 |
| Purchase of property and equipment | 21,829 | 51,106 | 18,010 | 18,572 |
| Proceeds from the sale of assets | NaN | 750 | 0 | NaN |
| Net cash used in investing activities | -126,961 | -118,146 | -97,058 | -32,405 |
| Borrowing on line of credit | 45,000 | 0 | 0 | 0 |
| Payments on line of credit | 100,000 | 0 | 42,000 | 0 |
| Borrowings of long-term debt, net of deferred financing fees | NaN | 0 | 0 | 0 |
| Payments on long-term debt | 1,439 | 5,470 | 3,726 | 4,957 |
| Noncontrolling interest distribution | 208 | -1 | 158 | 220 |
| Contributions from noncontrolling interest | NaN | 0 | 0 | 0 |
| Dividends on common stock | NaN | 0 | 0 | 0 |
| Proceeds from initial public offering, net of issuance costs | NaN | 0 | 0 | 0 |
| Proceeds from common stock offering, net of issuance costs | NaN | 0 | 0 | NaN |
| Purchase of equity in noncontrolling interest | 404 | NaN | NaN | NaN |
| Taxes paid related to net share settlement of stock-based compensation awards | 10,663 | 0 | 440 | 7,955 |
| Net cash used in financing activities | -67,714 | -5,469 | -46,324 | -13,132 |
| Net change in cash | 41,660 | -127,005 | 61,414 | 7,037 |
| Cash, cash equivalents, and restricted cash - beginning of period | 232,051 | 359,056 | 297,642 | 290,605 |
| Cash, cash equivalents, and restricted cash - end of period | 273,711 | 232,051 | 359,056 | 297,642 |